Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Use of prescription medications with a potential for fetal harm among pregnant women.

Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):546-54.

PMID:
16586470
2.

Prescription drug use in pregnancy.

Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R.

Am J Obstet Gynecol. 2004 Aug;191(2):398-407.

PMID:
15343213
3.

National patterns of medication use during pregnancy.

Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK, Xue Z.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):537-45.

PMID:
16700083
4.

Prescription of teratogenic medications in United States ambulatory practices.

Schwarz EB, Maselli J, Norton M, Gonzales R.

Am J Med. 2005 Nov;118(11):1240-9.

PMID:
16271908
5.

Outpatient use of cardiovascular drugs during pregnancy.

Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Dal Pan GJ, Scott PE, Platt R.

Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):240-7. doi: 10.1002/pds.1550.

PMID:
18200619
6.

Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.

Yang T, Walker MC, Krewski D, Yang Q, Nimrod C, Garner P, Fraser W, Olatunbosun O, Wen SW.

Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):270-7. doi: 10.1002/pds.1538.

PMID:
18181228
7.

Provision of potentially teratogenic medications to female veterans of childbearing age.

Schwarz EB, Longo LS, Zhao X, Stone RA, Cunningham F, Good CB.

Med Care. 2010 Sep;48(9):834-42. doi: 10.1097/MLR.0b013e3181e57946.

PMID:
20706159
8.

Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.

van Gelder MM, Bos JH, Roeleveld N, de Jong-van den Berg LT.

Hum Reprod. 2014 Jan;29(1):161-7. doi: 10.1093/humrep/det369. Epub 2013 Oct 8.

PMID:
24105826
9.

Patterns of medication use during pregnancy in rheumatoid arthritis.

Kuriya B, Hernández-Díaz S, Liu J, Bermas BL, Daniel G, Solomon DH.

Arthritis Care Res (Hoboken). 2011 May;63(5):721-8. doi: 10.1002/acr.20422.

10.

Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group.

Olesen C, Sørensen HT, de Jong-van den Berg L, Olsen J, Steffensen FH.

Acta Obstet Gynecol Scand. 1999 Sep;78(8):686-92.

PMID:
10468060
11.

Use of antidepressant medications during pregnancy: a multisite study.

Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R.

Am J Obstet Gynecol. 2008 Feb;198(2):194.e1-5. Epub 2007 Oct 1.

PMID:
17905176
12.

Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).

Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG.

Clin Ther. 2012 Jan;34(1):239-249.e2. doi: 10.1016/j.clinthera.2011.11.025. Epub 2011 Dec 14.

PMID:
22169049
13.

Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.

Vroom F, van Roon EN, van den Berg PB, Brouwers JR, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):52-61.

PMID:
17948319
14.

Prescriptions filled during pregnancy for drugs with the potential of fetal harm.

Kulaga S, Zargarzadeh AH, Bérard A.

BJOG. 2009 Dec;116(13):1788-95. doi: 10.1111/j.1471-0528.2009.02377.x. Epub 2009 Oct 13. Erratum in: BJOG. 2010 Feb;117(3):373. Zagarzadeh, A [corrected to Zargarzadeh, A H].

15.

Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.

Kebede B, Gedif T, Getachew A.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):462-8. doi: 10.1002/pds.1732.

PMID:
19334033
16.

Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database.

Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):555-64.

PMID:
16767799
17.

FDA drug prescribing warnings: is the black box half empty or half full?

Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):369-86.

PMID:
16294363
18.

Physician characteristics and prescription drug use during pregnancy: a population-based study.

Weng SS, Chen YH, Lin CC, Keller JJ, Wang IT, Lin HC.

Ann Epidemiol. 2013 Feb;23(2):54-9. doi: 10.1016/j.annepidem.2012.11.007. Epub 2012 Dec 5.

PMID:
23218810
19.

Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study.

Rohra DK, Das N, Azam SI, Solangi NA, Memon Z, Shaikh AM, Khan NH.

BMC Pregnancy Childbirth. 2008 Jul 15;8:24. doi: 10.1186/1471-2393-8-24.

20.

Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.

Zomerdijk IM, Ruiter R, Houweling LM, Herings RM, Straus SM, Stricker BH.

BJOG. 2015 Jul;122(8):1119-29. doi: 10.1111/1471-0528.13128. Epub 2014 Oct 15.

Supplemental Content

Support Center